Sign in

CIK 0001429260

  • Non-accelerated filer
  • Smaller reporting company

Fortress Biotech, Inc.

Sign in to watch
Ticker
FBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
205157386
Phone
+1 781-652-4500
Business address
1111 KANE CONCOURSE, SUITE 301, BAY HARBOR ISLANDS, FL, 33154
Former names
Fortress Biotech, Inc., CORONADO BIOSCIENCES INC

Securities

  • FBIO Common Stock Nasdaq
  • FBIOP 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock Nasdaq
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 47 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2013-12-19 WEISS MICHAEL S Director Grant or award +1,979,346 1,979,346
2013-12-19 WEISS MICHAEL S Director Grant or award · Options to purchase Common Stock +30,000 30,000
2013-12-19 ROSENWALD LINDSAY A MD President and CEO Grant or award +1,979,346 4,638,347
2013-12-19 Harvey Jimmie Director Grant or award · Options to purchase Common Stock +30,000 30,000
2013-12-19 BARRETT DAVID JONATHAN Director Grant or award · Options to purchase Common Stock +30,000 30,000
2013-12-04 Lu Lucy Chief Financial Officer Purchase +1,107 $1.39 $2K 25,631
2013-11-05 HORGAN KEVIN Chief Medical Officer Grant or award · Options to purchase Common Stock +200,000 200,000
2013-08-21 Lu Lucy Chief Financial Officer Purchase +5,000 $7.38 $37K 24,524
2013-08-21 LOBELL J JAY Director Purchase +5,000 $7.37 $37K 336,000
2013-07-17 Lu Lucy Chief Financial Officer Purchase +4,545 $7.90 $36K 19,524
2012-01-23 ROSENWALD LINDSAY A MD President and CEO Purchase +2,000 $6.95 $14K 2,461,001

Page 12 of 12 · 231 trades